According to a report available on Radiant Insights, Inc.; the 3D cell Culture market is likely to grow significantly by 2025. Increasing awareness, growing focus on developing substitute techniques for animal testing, supportive efforts and funding from government, rising awareness, and technological advancements can propel the market during the forecast period(2018 to 2025).In addition, high prevalence of cancer and increasing funding for cancer research from government and private organizations can create positive outlook for the market. Development of novel scaffolds and matrices along with advancements in research and analytical processes can have positive impact on the market. Three-dimensional cellular models are obtained using a range of structural hydrogels and scaffolds. But, researchers find it difficulties while obtaining 3D cellular model with scaffolds, as it obstructs cell-to-cell exchanges and interfere in assembly of extracellular matrices.
Introduction of scaffold-free technology for the development of translational pathway for tissues can positively drive the market. Additionally, advancements in 3D bio printing that helps to fabricate scaffold-free tissue units over fusion of tissue spheroids, allows development of functional tissue-engineered constructs with different 3D structures. These developments are also likely to boost the market growth in the coming years. Moreover, development of cellular models for differentiation and expansion of pluripotent stem cells created on principle of scaffolding can create lucrative opportunities in stem cell research applications.
Request a Free Sample Copy of this Report @ https://www.radiantinsights.com/research/global-3d-cell-culture-market-professional-survey-report-2018/request-sample
Worldwide 3Dculture market can be segmented on the basis of product, application, and region. As per product; the market can be classified into scaffold-based and scaffold-free. Based on application, the market can be categorized into stem cell research, cancer research, drug discovery, and regenerative medicine. Geographically, the market can be divided into North America, Europe, Japan, China, Southeast Asia, and India. North America reported as the largest markets due to high prevalence of chronic diseases in the U.S. and Canada. This has encouraged major players to develop 3D cellular culture products for cell-based therapeutics. Existence of various pharma and biotech companies and their efforts to develop the technology can create positive outlook for the market.
Europe is anticipated to show rapid growth during the forecast period. This growth can be attributed to the rising incidences of cancer, growing venture capital investments, strategic expansion of companies in the region, accessibility of technologically advanced products, and increasing awareness of the technology via symposia, conferences, forums, and workshops. Southeast Asia and other Asian countries such as India, China, and Japan are likely to show significant growth in the coming years on account of increasing demand for drug discovery and development of biotechnology industry in these countries. Factors such as growing government investments, comparatively less operating costs of laboratory settings and growing government investments for healthcare infrastructure owing to increasing cases of cancers can boost the market in these countries.
Download Full Research Report @ https://www.radiantinsights.com/research/global-3d-cell-culture-market-professional-survey-report-2018
Major participants in the market include 3D Biotek, Thermo Fisher Scientific, Merck Kgaa, Reprocell Incorporated, and Lonza Group. Major market participants are collaborating with laboratories for commercialization of technologies. For instance, StemTek Therapeutics recently introduced 3D cell culture kitCell2Sphere. This kit can be used for personalized medicine, pharmaceutical drug development, and cancer stem cell research. It is a scalable solution for High-throughput screening (HTS) and identifying genetic changes in cancer stem cells. Its 3D spheroids can provide accurate, complete, reproducible data for in vitro to in vivo estimates in the search for therapeutic compounds and designer molecules to stop cancer.
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: Send Email
Phone: (415) 349-0054, Toll Free: 1-888-928-9744
Address:201 Spear Street 1100, Suite 3036
City: San Francisco
Country: United States